Shaji K. Kumar, MD¹, Prashant Kapoor, MD², Betsy Laplant, MS^3*, Liang Phuong-Dung^4*, Eli Muchtar, MD^2*, Francis K. Buadi, MB, CHB^2*, Wilson I Gonsalves, MD⁵, Gabriella C Malave, BA^5*, Alanna M. Vossen^5*, David Dingli, MD, PhD², Ronald S. Go, MD⁶, Rahma M Warsame, MD⁴, Taxiarchis Kourelis, MD², Yi L. Hwa, NP⁵, Amie Fonder, PA-C, MS^5*, Miriam A. Hobbs, APRN, CNP, DNP^5*, John A. Lust, MD, PhD⁵, Martha Q. Lacy, MD², Angela Dispenzieri, MD⁴, Suzanne R. Hayman, MD⁵, Nelson Leung, MD², S. Vincent Rajkumar, MD² and Morie Gertz²

¹Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic Rochester, Division of Hematology, Rochester, MN
³Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Mayo Clinic Rochester, Division of Hematology, Onalaska, WI

Dan T. Vogl, MD¹, Jonathan L. Kaufman, MD², Sarah A. Holstein, MD, PhD³, Omar Nadeem, MD⁴, Elizabeth O’Donnell, MD^5*, Kaveri Suryanarayan, MD^6*, Sabrina Collins^7*, Xavier Parot, MD^6* and Maria Chaudhry, MD⁸

¹University of Pennsylvania, Philadelphia, PA
²Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
³University of Nebraska Medical Center, Omaha, NE
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
⁶Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁷Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company, Cambridge, MA
⁸Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Muhamad Alhaj Moustafa, MD¹, Ricardo Parrondo, MD², Mays F Abdulazeez, MBBS³, Vivek Roy, MD⁴, Taimur Sher, MD¹, Victoria R. Alegria^3*, Rahma M Warsame, MD⁵, Jeremy Larsen⁶, Wilson I Gonsalves, MD⁵, Taxiarchis Kourelis, MD⁵, Prashant Kapoor, MD⁵, Rafael Fonseca, MD⁷, Francis K. Buadi, MB, CHB^5*, David Dingli, MD, PhD⁵, Suzanne R. Hayman, MD⁸, Craig B. Reeder, MD⁹, Arshi Agrawal^10*, Asher Chanan-Khan, MBBS, MD¹¹ and Sikander Ailawadhi, MD¹¹

¹Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
²Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
³Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁴Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
⁵Mayo Clinic, Rochester, MN
⁶Mayo Clinic, Phoenix, AZ
⁷Mayo Clinic in Arizona, Phoenix, AZ
⁸Division of Hematology, Mayo Clinic, Rochester, MN
⁹Mayo Clinic, Scottsdale, AZ
¹⁰Mayo Clinic, Jacksonville
¹¹Mayo Clinic, Jacksonville, FL

Matthew J Frigault, MD, MSc¹, Michael R. Bishop, MD², Elizabeth K. O'Donnell, MD³, Noopur S. Raje, MD⁴, Allegra Mondillo^5*, Daniella Cook^5*, Heather Daley^6*, Carissa Mangus^7*, David W LeFleur^8*, Janine M Buonato^8*, Justin P Edwards^9*, Laura K Richman, DVM, PhD^10*, Maria T Polianova, PhD^10*, Maria Sabatino, MD^10*, Scott Currence^10*, Angela Shen, MD^10*, Travis Quigley, MS^9* and Marcela V. Maus, MD, PhD¹¹

¹Blood and Marrow Transplant Program, Massachusetts General Hospital / Harvard Medical School, Dorchester, MA
²Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
³Massachusetts General Hospital Cancer Center, Boston, MA
⁴Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Boston, MA
⁵Cancer Center, Massachusetts General Hospital, Boston, MA
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷CE3, Inc.,, Clinton, CT
⁸Arcellx, Inc, Gaithersburg, MD
⁹Arcellx, Inc., Gaithersburg
¹⁰Arcellx, Inc., Gaithersburg, MD
¹¹Massachusetts General Hospital, Harvard Medical School, Boston, MA

Saulius K. Girnius, MD¹, Habte A. Yimer, MD², Stephen J. Noga, MD, PhD³, Sudhir Manda, MD⁴, Roger M. Lyons, MD⁵, Kimberly Bogard, PharmD^3*, Presley Whidden^3*, Dasha Cherepanov^3*, Vickie Lu, PhD^3*, Jack Aiello, EE, MS, BS^6*, Joshua R. Richter, MD⁷ and Robert M. Rifkin, MD⁸

¹Trihealth Cancer Institute, Cincinnati, OH
²Texas Oncology/US Oncology Research, Tyler, TX
³Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁴Arizona Oncology/US Oncology Research, Tucson, AZ
⁵Texas Oncology/US Oncology Research, San Antonio, TX
⁶Patient Empowerment Network, San Jose, CA
⁷Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO

Jacob P. Laubach, MD¹, Fredrik Schjesvold, MD, PhD², Mário Mariz³, Meletios A Dimopoulos⁴, Ewa Lech-Marańda, MD, PhD^5*, Ivan Spicka, MD, PhD^6*, Vania T. M. Hungria, MD, PhD⁷, Tatiana Shelekhova^8*, Andre Abdo, MD^9*, Lutz Jacobasch^10*, Chantana Polprasert, MD^11*, Roman Hajek, MD, PhD¹², Arpad Illes, MD^13*, Tomasz Wróbel, MD, PhD¹⁴, Anna Sureda Balari, MD, PhD^15*, Meral Beksac, MD¹⁶, Iara Goncalves^17*, Joan Bladé Creixenti¹⁸, S. Vincent Rajkumar, MD¹⁹, Ajai Chari, MD²⁰, Sagar Lonial, MD²¹, Andrew Spencer²², Pierre Maison-Blanche^23*, Philippe Moreau^24*, Paul G. Richardson, MD²⁵ and Jesus F. San-Miguel, MD, PhD²⁶

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Oslo Myeloma Center, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
³Department of Onco-Hematology, Portuguese Institute of Oncology, Porto, Portugal
⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁵Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
⁶Charles University and General Hospital, Prague, Czech Republic
⁷São Germano Clinic, São Paulo, Brazil
⁸Saratov State Medical University, Saratov, Russian Federation
⁹University of Sao Paulo, Faculty of Medicine Hospital, São Paulo, Brazil
¹⁰Group Practice Freiberg-Richter, Dresden, Germany
¹¹Chulalongkorn University, Bangkok, Thailand
¹²​Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, Ostrava, Czech Republic
¹³Department of Hematology, University of Debrecen, Faculty of Medicine, Debrecen, Hungary
¹⁴Wrocław Medical University, Wrocław, Poland
¹⁵Institut Català d'Oncologia-Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
¹⁶Ankara University, Department of Hematology, Ankara, Turkey
¹⁷Fundacao Pio XII Barretos Cancer Hospital, Barretos, Brazil
¹⁸Hospital Clinic de Barcelona, Barcelona, Spain
¹⁹Division of Hematology, Mayo Clinic, Rochester, MN
²⁰Icahn School of Medicine at Mount Sinai, New York, NY
²¹Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
²²Alfred Health-Monash University, Melbourne, Australia
²³Bichat - Claude-Bernard Hospital (Paris Nord Val de Seine University Hospitals), Paris, France
²⁴Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France
²⁵Dana-Farber Cancer Institute, Boston, MA
²⁶University of Navarra, Pamplona, Spain

Alex Ge^1*, Chiung-Yu Huang, PhD^2*, Thomas Martin III, MD³, Jeffrey L. Wolf, MD³, Nina Shah, MD⁴ and Sandy W. Wong, MD⁵

¹School of Medicine, University of California, San Francisco, San Francisco, CA
²Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA
³University of California, San Francisco, San Francisco, CA
⁴Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
⁵Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA

Nadjoua Maouche^1*, Bhuvan Kishore^2*, Bhatti Zara^2*, Supratik Basu^3*, Farheen Karim^3*, Sharadha Sundararaman^3*, Freya Collings^4*, Tseu Bing^5*, Heather Leary^6*, Noel Ryman^7*, Udaya Reddy^7*, Grant Vallance^1*, Jaimal Kothari^1*, Faouzi Djebbari^1* and Karthik Ramasamy¹

¹Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
³The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom
⁴Great Western Hospitals NHS Foundation Trust, Swindon, United Kingdom
⁵Buckinghamshire Healthcare NHS Trust, Bucks, United Kingdom
⁶Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, United Kingdom
⁷Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom

Ola Landgren, MD, PhD¹, Malin Hultcrantz, MD, PhD¹, Alexander M. Lesokhin, MD¹, Sham Mailankody, MBBS¹, Hani Hassoun, MD¹, Carlyn Tan, MD¹, Urvi A Shah, MD¹, Sydney X. Lu, MD, PhD¹, Benjamin Diamond, MD¹, Meghan Salcedo, RN^1*, Kelly Werner, RN^1*, Jenna Rispoli, RN^1*, Julia Caple, RN^1*, Allison Sams, NP^1*, Dennis Verducci, NP^1*, Katie Jones, NP^1*, Isabel Concepcion, NP^1*, Ciardello Amanda, MS^1*, Aisara Chansakul, BS^1*, Julia Schlossman, BA^1*, Elizabet Tavitian, BS^1*, Tala Shekarkhand, BS^1*, Angela Harrison, MS^1*, Casey Piacentini, BS^1*, Even H Rustad, MD, PhD^1*, Venkata Yellapantula, PhD^1*, Francesco Maura, MD¹, Heather J Landau, MD², Michael Scordo, MD³, David J. Chung, MD, PhD⁴, Gunjan Shah, MD^5*, Oscar B Lahoud, MD⁶, Katie Thoren^7*, Kazunori Murata, PhD^7*, Lakshmi Ramanathan, PhD^7*, Maria E. Arcila, MD^8*, Caleb Ho, MD⁸, Mikhail Roshal, MD, PhD⁸, Ahmet Dogan, MD, PhD⁸, Andriy Derkach, PhD^1*, Sergio A. Giralt, MD⁹ and Neha Korde, MD¹

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, Scarsdale, NY
³Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Brooklyn, NY
⁷Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Luca Biavati, MD^1*, Carol Ann Huff, MD², Anna Ferguson, BSN, RN^3*, Lakshmi Rudraraju, MS^3*, Cristina Zucchinetti^4*, Rachel Gittelman^5*, Sarah Johnson^5*, Catherine Sanders^5*, Abbas Abbas Ali, MD⁶, Kimberly Noonan, PhD, MPH^3* and Ivan M. Borrello, MD²

¹Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD
²Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
³Johns Hopkins University, Baltimore, MD
⁴Johns Hopkins University, Baltimore
⁵Adaptive Biotech, Seattle, WA
⁶Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD

Alexander M. Lesokhin, MD¹, Moshe Y. Levy, MD², Andrew P. Dalovisio, MD³, Nizar Bahlis, MD⁴, Melhem Solh, MD⁵, Michael Sebag, MD, PhD⁶, Andrzej Jakubowiak, MD, PhD⁷, Yogesh S. Jethava, MBBS, MD, FRCPath, MRCP⁸, Caitlin L. Costello, MD⁹, Michael P. Chu, MD¹⁰, Michael R. Savona, MD¹¹, Cristina Gasparetto, MD¹², Suzanne Trudel, MD, MSC, FRCPC¹³, Jeffrey Chou, MD, PhD^14*, Chandrasekhar Udata, PhD^15*, Cynthia Basu, PhD^15*, Heike I. Krupka, PhD, PMP^14* and Noopur S. Raje, MD¹⁶

¹Department of Hematology and Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
²Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
³Department of Hematology and Oncology, Ochsner Health, Jefferson, LA
⁴University of Calgary, Calgary, AB, Canada
⁵BMT Group of Georgia, Northside Hospital, Atlanta, GA
⁶Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
⁷University of Chicago, Chicago, IL
⁸Division of Hematology, Oncology, Blood and Marrow Transplantation, University of Iowa, Iowa City, IA
⁹Moores Cancer Center, University of California, San Diego, La Jolla, CA
¹⁰Department of Oncology, University of Alberta, Edmonton, AB, Canada
¹¹Department of Medicine and Program in Cancer Biology, Vanderbilt University Medical Center, Nashville, TN
¹²Department of Medicine, Duke Univ. Medical Center, Durham, NC
¹³Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁴Oncology Research and Development, Pfizer, San Francisco, CA
¹⁵Oncology Research and Development, Pfizer, San Diego, CA
¹⁶Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA

Saad Z. Usmani, MD, MBBS, MBA¹, Chatchada Karanes², William I Bensinger, MD^3*, Anita D'Souza, MD, MS⁴, Noopur S. Raje, MD⁵, Sascha A Tuchman, MD⁶, Douglas Sborov, MD, MS⁷, Dheepak Kanagavel^8*, Rao Saleem^9*, Franck Dubin^10*, Frank Campana, MD^11* and Paul G. Richardson, MD^12,13

¹Levine Cancer Institute/Carolinas HealthCare System, Charlotte, NC
²Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
³Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
⁴Medical College of Wisconsin, Milwaukee, WI
⁵Cancer Center, Massachusetts General Hospital, Boston, MA
⁶University of North Carolina, Chapel Hill, NC
⁷Division of Hematology & Hematologic Malignancies, University of Utah, Salt Lake City, UT
⁸Sanofi, Vitry-Alfortville, FRA
⁹Sanofi, Cambridge, MA
¹⁰Sanofi R&D, Vitry-Alfortville, France
¹¹Sanofi Genzyme, Cambridge, MA
¹²Harvard Medical School, Boston, MA
¹³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Xavier Leleu, MD¹, Borhane Slama, MD^2*, Renato Zambello^3*, Sorina Nicoleta Badelita, MD^4*, Eirini Katodritou, MD^5*, Jo Caers, MD, PhD^6*, Thomas Kühr, MD^7*, Florence Suzan, MD^8*, Abeera Mohammad, MSc^9*, Sally Wetten, MSc^10* and Evangelos Terpos, MD, PhD¹¹

¹Department of Oncology-Haematology and Cell Therapy, CHU Poitiers, INSERM, Inserm CIC 1402, Poitiers, France
²Service d'Hématologie, Centre Hospitalier d'Avignon, Avignon, France
³Hematology and Clinical Immunology, Department of Medicine, Azienda Ospedaliera di Padova, Padova, Italy
⁴Institutul Clinic Fundeni, Bucharest, Romania
⁵Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁶Department of Hematology, CHU de Liège, Liege, Belgium
⁷Department of Internal Medicine IV, Academic Teaching Hospital Wels-Grieskirchen, Wels, Austria
⁸Amgen (Europe) GmbH, Rotkreuz, Switzerland
⁹Global Biostatistical Science, Amgen Ltd, Uxbridge, United Kingdom
¹⁰Centre for Observational Research, Amgen Ltd, Uxbridge, United Kingdom
¹¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Niels W.C.J. Van De Donk¹, Sonja Zweegman, MD, PhD², Jesus F. San-Miguel, MD, PhD³, Meletios A Dimopoulos⁴, Michele Cavo^5*, Kenshi Suzuki, MD, PhD⁶, Cyrille Touzeau^7*, Saad Z. Usmani, MD, MBBS, MBA⁸, Aurore Perrot, MD, PhD^9*, Huiling Pei, PhD^10*, Anupa Kudva, MD^11*, Rian Van Rampelbergh^12*, Jon Ukropec, PhD¹³, Kevin Leary^14*, Robin Carson, MD, BA¹⁴, Ming Qi, MD, PhD¹⁴ and Ajai Chari^15*

¹Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands
²Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
³Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
⁴National and Kapodistrian University of Athens, Athens, Greece
⁵Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁶Japanese Red Cross Medical Center, Department of Hematology, Tokyo, Japan
⁷Hematology, University Hospital Hôtel-Dieu, Nantes, France
⁸Levine Cancer Institute, Charlotte, NC
⁹CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
¹⁰Janssen Research & Development, LLC, Titusville, NJ
¹¹Janssen Research & Development, Raritan, NJ
¹²Janssen Research & Development, Beerse, Belgium
¹³Janssen Global Medical Affairs, Horsham, PA
¹⁴Janssen Research & Development, LLC, Spring House, PA
¹⁵Icahn School of Medicine at Mount Sinai, New York, NY

Maria Gavriatopoulou^1*, Ioannis Ntanasis-Stathopoulos, MD^1*, Panagiotis Malandrakis, MD^1*, Despina Fotiou, MD^1*, Magdalini Migkou^2*, Nikolaos Kanellias, MD^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Ioanna Dialoupi, MD^1*, Foteini Theodorakakou, MD^1*, Maria Roussou, MD^1*, Evangelos Terpos, MD, PhD¹, Efstathios Kastritis, MD^3* and Meletios A. Dimopoulos, MD¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²National and Kapodistrian University of Athens, Athens, Greece
³National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Karthik Ramasamy¹, Ajay Nooka, MD, MPH², Hang Quach, MD, FRACP, FRCPA, MBBS³, Myo Htut, MD⁴, Rakesh Popat^5*, Michaela Liedtke, MD⁶, Sascha A Tuchman, MD⁷, Jacob P. Laubach, MD⁸, Cristina Gasparetto, MD⁹, Asher Chanan-Khan, MBBS, MD¹⁰, Mark Hertzberg, MBBS PhD FRACP FRCPA¹¹, Mark Demario, MD, MPH^12*, Eveline Nueesch, PhD^13*, Evelyne Chesne, PhD^13*, Izolda Franjkovic, PhD^14*, Katharina Lechner^14*, Martin Kornacker, MD¹³ and Hearn Jay Cho, MD, PhD¹⁵

¹Department of Haematology, Oxford University Hospital, NHS Trust, Oxford, United Kingdom
²Winship Cancer Institute, Emory University, Atlanta, GA
³Melbourne Blood Specialist, East Melbourne, VIC, Australia
⁴City of Hope Comprehensive Cancer Center, Duarte, CA
⁵University College London Hospitals, NHS Foundation Trust, London, United Kingdom
⁶Division of Hematology, Department of Medicine, Stanford University, Stanford, CA
⁷University of North Carolina, Chapel Hill, NC
⁸The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, MA
⁹Department of Medicine, Duke Univ. Medical Center, Durham, NC
¹⁰Division of Hematology and Medical Oncology, Professor of Medicine, Mayo Clinic, Jacksonville, FL
¹¹Department of Clinical Haematology, Prince of Wales Hospital, Sydney, Australia
¹²Roche Pharma Research and Early Development, New York, NY
¹³Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland
¹⁴Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany
¹⁵MMRF; Icahn School of Medicine at Mount Sinai, Norwalk, CT

Lukas John^1*, Kaya Miah^2*, Axel Benner^2*, Elias K Mai, MD^1*, Katharina Kriegsmann, MD^1*, Michael Hundemer, MD^1*, Carsten Mueller-Tidow, MD^1,3*, Karin Jordan, MD^1*, Hartmut Goldschmidt, MD^1,3, Marc S. Raab, MD^1* and Nicola Giesen, MD^1*

¹Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
²Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
³National Center for Tumor Diseases Heidelberg, Heidelberg, Germany

Rin Nakamura^1*, Sean Lear^1*, Deanna Wilson^1*, Hartmut Koeppen^1*, Anjali Vaze^1*, Suzanne Trudel, MD, MSC, FRCPC², Andrew Spencer³, Simon J Harrison, MBBS MRCP (UK) PhD FRCPath (UK) FRACP⁴, Adam D. Cohen, MD⁵, Bernard M Fine^1*, Mengsong Li^1*, James Cooper^1* and Teiko Sumiyoshi^1*

¹Genentech, Inc., South San Francisco, CA
²Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada
³Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia
⁴Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
⁵University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA

Paul G. Richardson, MD¹, María-Victoria Mateos, MD, PhD², Albert Oriol^3*, Alessandra Larocca⁴, Michele Cavo^5*, Paula Rodríguez-Otero, MD, PhD^6*, Xavier Leleu, MD⁷, Maxim Norkin, MD, PhD^8*, Omar Nadeem, MD^1*, John W. Hiemenz, MD^9*, Hani Hassoun, MD¹⁰, Cyrille Touzeau^11,12,13*, Adrián Alegre Amor, MD, PhD^14*, Agne Paner, MD¹⁵, Christopher Maisel, MD¹⁶, Amitabha Mazumder, MD^17*, Anastasios Raptis, MD¹⁸, Noemí Puig, MD, PhD^2*, Elena Zamagni, MD^19*, Marcus Thuresson, PhD^20*, Johan Harmenberg, MD, PhD²⁰, Olof Harlin, VMD, PhD^20* and Joan Blade Creixenti²¹

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
³Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁴Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy
⁵Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁶Clínica Universidad de Navarra, Pamplona, Spain
⁷CHU de Poitiers, Poitiers, France
⁸Baptist MD Anderson Cancer Center, Jacksonville, FL
⁹Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, FL
¹⁰Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université d'Angers, Université de Nantes, Nantes, France
¹²Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France
¹³Service d'hématologie Clinique, Centre Hospitalier Universitaire, Place Alexis Ricordeau, Nantes, France
¹⁴Hospital Universitario La Princesa and Hospital Universitario Quironsalud, Madrid, Spain
¹⁵Rush University Medical Center, Chicago, IL
¹⁶Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX
¹⁷The Oncology Institute of Hope and Innovation, Glendale, CA
¹⁸Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
¹⁹University of Bologna, Bologna, Italy
²⁰Oncopeptides AB, Stockholm, Sweden
²¹Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain

Holger W Auner, MD, PhD¹, Maria Gavriatopoulou^2*, Sosana Delimpasi, MD^3*, Maryana Simonova, MD^4*, Ivan Spicka, MD, PhD^5*, Ludek Pour, MD^6*, Meletios A Dimopoulos⁷, Irina Kryachok, Professor^8*, Halyna Pylypenko, MD^9*, Xavier Leleu, MD¹⁰, Vadim A Doronin, MD^11*, Ganna Usenko, MD^12*, Roman Hajek, MD¹³, Reuben Benjamin, FRCPath, MRCP, MBBS, PhD^14*, Tuphan Kanti Dolai, MBBS, MD, DNB, DM^15*, Dinesh Kumar Sinha, MD^16*, Christopher P. Venner, MD¹⁷, Mamta Garg, MD, FRCP, FRCPath^18*, Don A. Stevens, MD¹⁹, Hang Quach, MD, FRACP, FRCPA, MBBS²⁰, Sundar Jagannath, MD²¹, Philippe Moreau^22*, Moshe Y. Levy, MD²³, Ashraf Z. Badros, MD²⁴, Larry D. Anderson Jr., MD, PhD²⁵, Nizar Bahlis, MD²⁶, Thierry Facon, MD^27*, Maria Mateos, MD, PhD^28*, Michele Cavo^29*, Anita A. Joshi^30*, Yi Chai^31*, Melina Arazy, MD^30*, Jatin Shah, MD³¹, Sharon Shacham, PhD, MBA^31*, Michael G Kauffman, MD, PhD³¹, Paul G. Richardson, MD³² and Sebastian Grosicki, MD, PhD³³

¹Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom
²Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens,, Athens, Greece
³Department of Haematology, General Hospital of Athens, Athens, Greece
⁴Institute of Blood Pathology & Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, MA, Ukraine
⁵Charles University and General Hospital, Prague, Czech Republic
⁶University Hospital Brno, Brno, CZE
⁷Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
⁸Oncohematology, National Cancer Institute, Kyiv, Ukraine
⁹Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine
¹⁰CHU de Poitiers - Hôpital La Milétrie, Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, POITIERS, France
¹¹Hematology Department, State Budget Healthcare Institution of Moscow, City Clinical Hospital #40 of Moscow Healthcare Department, Moscow, Russian Federation
¹²City Clinical Hospital No. 4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine
¹³University Hospital Ostrava, Ostrava, Czech Republic
¹⁴King's College Hospital NHS Foundation Trust, London, United Kingdom
¹⁵Haematology, NRS Medical College and Hospital, Kolkata, India
¹⁶Indira Gandhi Institute of Medical Sciences, Patna, India
¹⁷Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
¹⁸Sandringham Building 2nd Floor, Leicester Royal Infirmary, Leicester, United Kingdom
¹⁹Norton Cancer Institute - St Matthews Campus, Louisville, KY
²⁰Melbourne Blood Specialist, East Melbourne, VIC, Australia
²¹Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²²Department of Hematology, University Hospital of Nantes, Nantes, France
²³Baylor University Medical Center, Dallas, TX
²⁴The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD
²⁵UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX
²⁶University of Calgary, Calgary, AB, Canada
²⁷Bordeaux Hospital University Center (CHU), Lille, France
²⁸Hospital Clinico Universitario de Salamanca, Salamanca, Spain
²⁹Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
³⁰Karyopharm Therapeutics Inc., Newton, MA
³¹Karyopharm Therapeutics, Newton, MA
³²Dana-Farber Cancer Institute, Boston, MA
³³Silesian Medical University, Katowice, Poland

Erin K. Yeung, Pharm.D.^1*, Brian R. Primeaux, Pharm.D.^1*, Sandra B. Horowitz, Pharm.D.^1*, Brandon R. Shank^1*, Irene Y. Lee^1*, Gregory P. Kaufman, MD^2*, Hans C. Lee, MD³, Elisabet E. Manasanch, M.D.², Krina K. Patel, M.D.⁴, Robert Z. Orlowski, MD, PhD⁵, Donna M. Weber, MD² and Sheeba K. Thomas, MD²

¹Pharmacy Clinical Programs, University of Texas M.D. Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Raija Helena Silvennoinen, MD, PhD^1,2, Hareth Nahi, MD, PhD^3*, Pekka Anttila, MD^1*, Perttu Koskenvesa, MD^4*, Juha Lievonen, MD^1*, Anu Marttila, MD^5*, Ville Varmavuo, MD, PhD^5*, Anu Sikiö, MD^6*, Marita Nurmi, MD^6*, Marjaana Säily, MD, PhD^7*, Anu Partanen, MD, PhD^2*, Marja Sankelo, MD, PhD^8*, Sini Luoma, MD^1*, Pentti Mäntymaa, MD, PhD^9*, Sorella Ilveskero, MD, PhD^10*, Henrik Rode Eshoj, PhD^11*, Lene Kongsgaard Nielsen, MD, PhD^12,13*, Esa Jantunen, MD, PhD^2,14,15* and Caroline A Heckman, PhD¹⁶

¹Helsinki University Hospital, Comprehensive Cancer Center Hematology and University of Helsinki, Helsinki, Finland
²Department of Medicine, Kuopio University Hospital, Kuopio, Finland
³Department of Medicine, Division of Hematology, Karolinska University Hospital of Huddinge, Karolinska Institutet Huddinge, Stockholm, Sweden
⁴Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Comprehensive Cancer Center, Helsinki, Finland
⁵Department of Medicine, Kymenlaakso Central Hospital, Kotka, Finland
⁶Department of Medicine, Central Finland Central Hospital, Jyväskylä, Finland
⁷Department of Internal Medicine, Hematology-Oncology Unit, Oulu University Hospital, Oulu, Finland
⁸Department of Hematology, Tampere University Hospital, Tampere, Finland
⁹Eastern Finland Laboratory Centre, Kuopio University Hospital, Kuopio, Finland
¹⁰Clinical Chemistry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
¹¹Quality of Life Research Center, Department of Haematology, Odense University Hospital, Odense, Denmark
¹²Quality of Life Research Center, Department of Haematology, Odense University Hospital, Odense, Denmark
¹³Department of Internal Medicine and Cardiology, Regional Hospital Viborg, Viborg, Denmark
¹⁴Clinical Medicine, University of Eastern Finland, Joensuu, Finland
¹⁵North Carelia Central Hospital, Joensuu, Finland
¹⁶Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland

Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP¹, Cindy Lin^2*, Xinhua Li^2*, Chandramouli Nagarajan, MBBS^3*, Sung-Soo Yoon, MD, PhD⁴ and Brian G.M. Durie, MD⁵

¹National University Cancer Institute of Singapore, Singapore, Singapore
²Singapore Cancer Research Institute, Singapore, Singapore
³Department of Hematology, Singapore General Hospital, Singapore, Singapore
⁴Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁵Cedars Sinai Cancer Center, Los Angeles, CA

Frida Bugge Askeland, MD^1,2*, Anne-Marie Rasmussen, PhD^1,2* and Fredrik Schjesvold, MD, PhD^2,3

¹Oslo Myeloma Center/Department of Hematology, Oslo University Hospital, Oslo, Norway
²KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
³Oslo Myeloma Center/Department of Hematology, OSLO Univeristy Hospital, Oslo, Norway

Huiyao Gu^1*, Jingsong He, MD^2*, Enfan Zhang^3* and Zhen Cai, MD, PhD^3*

¹Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China
³Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

Ajay Nooka, MD, MPH¹, Hans C. Lee, MD², Ashraf Z. Badros, MD³, Peter Voorhees, MD⁴, Malin Hultcrantz, MD, PhD⁵, Lionel Karlin, MD^6*, Bertrand Arnulf, MD^7*, Paul G. Richardson, MD⁸, Eric Zhi, PhD^9*, January Baron, MS^9*, Trisha Piontek, BSN^9*, Eric Lewis, MD^10*, Joanna Opalinska, MD, PhD⁹, Ira Gupta, MD^9*, Adam D. Cohen, MD¹¹ and Sagar Lonial, MD¹²

¹Winship Cancer Institute, Emory University, Atlanta, GA
²MD Anderson Cancer Center, Houston, TX
³University of Maryland School of Medicine, Baltimore, MD
⁴Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Benite, France
⁷Hematology/Oncology, Hôpital Saint-Louis, Paris, France
⁸Dana-Farber Cancer Institute, Boston, MA
⁹GlaxoSmithKline, Philadelphia, PA
¹⁰GlaxoSmithKline, Research Triangle Park, NC
¹¹University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA
¹²Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA

Robert E Smith, MD^1*, Mei Xue^1*, Stanley M. Marks, MD², Jeffrey A. Scott, MD^3*, Simon Blanc^1*, Neil Nagovski, MD⁴, Hunter Lambert^1* and Prateesh Varughese^1*

¹Integra Connect, West Palm Beach, FL
²University of Pittsburgh Medical Center, Pittsburgh, PA
³Integra Connect, Palm Beach Gardens, FL
⁴21st Century Oncology, Aventura, FL

Max S. Topp, MD¹, Johannes Duell, MD^2*, Mareike Mauser^3* and Hermann Einsele, MD⁴

¹Medizinische Klinik Und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
²Medizinische Klinik und Poliklinik II, University Wuerzburg, Wuerzburg, Bavaria, Germany
³Medizinische Klinik und Poliklinik II, Würzburg, Germany
⁴Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Wuerzburg, Germany

Sagar Lonial, MD¹, Ajay Nooka, MD, MPH¹, Praneetha Thulasi, MD^2*, Ashraf Z. Badros, MD³, Bennie H. Jeng, MD^4*, Natalie S. Callander, MD⁵, Douglas Sborov, MD, MS⁶, Brian E. Zaugg, MD^7*, Rakesh Popat^8*, Simona Degli Esposti, MD^9*, Julie Byrne, PhD^10*, Joanna Opalinska, MD, PhD¹⁰, January Baron, MS^10*, Trisha Piontek, BSN^10*, Ira Gupta, MD^10*, Reza Dana, MD, MSc, MPH^11*, Asim Farooq, MD^12* and Andrzej Jakubowiak, MD, PhD¹²

¹Emory University, Winship Cancer Institute, Atlanta, GA
²Emory Eye Center, Emory University, Atlanta, GA
³University of Maryland School of Medicine, Baltimore, MD
⁴Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD
⁵Carbone Cancer Center, University of Wisconsin, Madison, WI
⁶Huntsman Cancer Institute, University of Utah, Salt Lake Cty, UT
⁷Moran Eye Center, University of Utah, Salt Lake City, UT
⁸University College London Hospitals, NHS Foundation Trust, London, United Kingdom
⁹NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
¹⁰GlaxoSmithKline, Upper Providence, PA
¹¹Massachusetts Eye and Ear, Harvard Medical School, Boston, MA
¹²University of Chicago Medical Center, Chicago, IL

Heinz Ludwig, MD¹, Thomas Melchardt, MD, PhD^2*, Johannes Andel, MD^3*, Eberhard Gunsilius, MD^4*, Siegfried Sormann, MD^5*, Axel Hinke, PhD^6*, Bernd L. Hartmann, MD^7*, Klaus Podar, MD, PhD⁸, Wolfgang Willenbacher, MD, PhD^4,9, Alexander Egle, MD², Andreas Petzer, MD¹⁰, Niklas Zojer, MD^11*, Ewald Wöll, MD^12*, Reinhard Ruckser, MD^13*, Boris Bozic, MD^13*, Clemens A. Schmitt, MD¹⁴, Sigrid Machherndl-Spandl, MD^15*, Maria-Theresa Krauth, MD^16*, Martin Schreder, MD^11*, Hermine Agis, MD¹⁶, Christoph Tinchon, MD^17*, Michael Fillitz, MD^18* and Richard Greil, MD²

¹Wilhelminen Cancer Research Institute, c/o Department of Medicine I, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria
²Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria
³Department of Internal Medicine II, LKH Steyr, Steyr, Austria
⁴Department of Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria
⁵Department of Internal Medicine, University Clinic Graz, Graz, Austria
⁶CCRC Cancer Clinical Research Consulting, Düsseldorf, Germany
⁷Department of Internal Medicine II, LKH Rankweil, Rankweil, Austria
⁸Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Lower Austria, Austria
⁹Oncotyrol, Center for personalized Cancer Medicine, Innsbruck, Austria
¹⁰Department of Internal Medicine I, Ordensklinikum Linz - BHS, Linz, Austria
¹¹Department of Medicine I, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria
¹²Department of Internal Medicine, KH Zams, Zams, Austria
¹³Department of Medicine II, Clinic Donaustadt, Vienna, Austria
¹⁴Clinic for Internal Medicine 3, Kepler University Clinic Linz, Linz, Austria
¹⁵Department of Internal Medicine I, Ordensklinikum Linz Elisabethinen, Linz, Austria
¹⁶Department of Internal Medicine I, Divison of Hematology and Hemostaseology, Medical University Vienna, Vienna, Austria
¹⁷Department of Internal Medicine, LKH Hochsteiermark, Leoben, Austria
¹⁸Third Department of Internal Medicine, Hanusch Hospital, Vienna, Austria

Irene Manrique, PhD^1*, Richard Greil, MD², Johannes Andel, MD^3*, Siegfried Sormann, MD^4*, Bernd L. Hartmann, MD^5*, Klaus Podar, MD, PhD⁶, Alexander Egle, MD², Andreas Petzer, MD⁷, Niklas Zojer, MD^8*, Reinhard Ruckser, MD^9*, Boris Bozic, MD^9*, Clemens A. Schmitt, MD¹⁰, Sigrid Machherndl-Spandl, MD^11*, Hermine Agis, MD¹², Martin Schreder, MD^8*, Maria-Theresa Krauth, MD^12*, Christoph Tinchon, MD^13*, Michael Fillitz, MD^14*, Thomas Melchardt, MD, PhD^2*, Bruno Paiva, PhD^1* and Heinz Ludwig, MD¹⁵

¹Clinica Universidad de Navarra, Pamplona, Spain
²Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria
³Department of Internal Medicine II, LKH Steyr, Steyr, Austria
⁴Department of Internal Medicine, University Clinic Graz, Graz, Austria
⁵Department of Internal Medicine II, LKH Rankweil, Rankweil, Austria
⁶Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Lower Austria, Austria
⁷Department of Internal Medicine I, Ordensklinikum Linz - BHS, Linz, Austria
⁸Department of Medicine I, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria
⁹Department of Medicine II, Clinic Donaustadt, Vienna, Austria
¹⁰Clinic for Internal Medicine 3, Kepler University Clinic Linz, Linz, Austria
¹¹Department of Internal Medicine I, Ordensklinikum Linz Elisabethinen, Linz, Austria
¹²Department of Internal Medicine I, Divison of Hematology and Hemostaseology, Medical University Vienna, Vienna, Austria
¹³Department of Internal Medicine, LKH Hochsteiermark, Leoben, Austria
¹⁴Third Department of Internal Medicine, Hanusch Hospital, Vienna, Austria
¹⁵Wilhelminen Cancer Research Institute, c/o Department of Medicine I, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria

Phoebe Joy Ho, MBBS, DPhil, FRACP, FRCPA^1,2, Elizabeth M. Moore, PhD^3*, Cameron Wellard^3*, Hang Quach, MD⁴, Hilary Blacklock^5*, Simon J Harrison, MBBS MRCP (UK) PhD FRCPath (UK) FRACP⁶, Emma-Jane McDonald, MRCP, FRCPath^7*, Zoe McQuilten, MBBS, PhD^3*, Erica M. Wood, MBBS, FRACP, FRCPA³, Peter Mollee, FRACP, MBBS, MSc, FRCPA⁸ and Andrew Spencer⁹

¹Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
²University of Sydney, Sydney, Australia
³School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
⁴St. Vincent’s Hospital, Fitzroy, VIC, Australia
⁵Middlemore Hospital, Auckland, New Zealand
⁶Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
⁷Department of Haematology, Canterbury District Health Board, Christchurch, NZL
⁸Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
⁹Department of Hematology, Monash University and Alfred Hospital, Melbourne, Australia

Angela Dispenzieri, MD¹, Shaji K. Kumar, MD², Francis K. Buadi, MB, CHB^2*, Martha Q. Lacy, MD², David Dingli, MD, PhD², Yi L. Hwa, NP¹, Amie Fonder, PA-C, MS^1*, Miriam A. Hobbs, APRN, CNP, DNP^1*, Suzanne R. Hayman, MD¹, Taxiarchis Kourelis, MD², Rahma M Warsame, MD³, Eli Muchtar, MD⁴, Nelson Leung, MD², Prashant Kapoor, MD², Martha Grogan, MD^5*, Yi Lin, MD, PhD⁶, Ronald S. Go, MD⁷, Wilson I Gonsalves, MD^1,2, Mustaqeem A. Siddiqui, MD, MBA¹, Robert A. Kyle, MD², John A. Lust, MD, PhD¹, S. Vincent Rajkumar, MD¹ and Morie A Gertz, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic Rochester, Division of Hematology, Rochester, MN
³Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Saint Paul, MN
⁵Cardiology, Mayo Clinic, Rochester, MN
⁶Mayo Clinic, Division of Hematology, Rochester, MN
⁷Mayo Clinic Rochester, Division of Hematology, Onalaska, WI

Paolo Milani, MD, PhD¹, Nelson Leung, MD², Efstathios Kastritis, MD^3*, Stefan Schönland, MD^4*, Ute Hegenbart, MD^5*, Frank Bridoux, MD^6*, Florent Joly, MD^7*, Sascha A Tuchman, MD⁸, Victor Jimenez-Zepeda, MD⁹, Sriram Ravichandran, MBBS, MRCP, FRCPath^10*, Holly Lee, MD¹¹, Tamara Berno, MD^12*, Giampaolo Merlini, MD¹³, Giovanni Palladini, MD, PhD¹⁴ and Ashutosh D. Wechalekar, MBBS, FRCP, FRCPath, DM¹⁵

¹Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
²Mayo Clinic Rochester, Division of Hematology, Rochester, MN
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece
⁴Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany
⁵Medicine V, University of Heidelberg, Heidelberg, Germany
⁶CHU Poitiers, Poitiers, FRA
⁷Department of Nephrology and Renal Transplantation, INSERM CIC 1402, Poitiers University Hospital, POITIERS, France
⁸University of North Carolina, Chapel Hill, NC
⁹Tom Baker Cancer Center, Department of Hematology, University of Calgary, Calgary, AB, Canada
¹⁰National Amyloidosis Centre, Royal Free Hospital, Leighton Buzzard, ENG, United Kingdom
¹¹Department of Internal Medicine, University of Calgary, Calgary, AB, Canada
¹²Hematology and Clinical Immunology, Department of Medicine, Padua University School of Medicine, Padova, ITA
¹³Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
¹⁴Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, PV, Italy
¹⁵University College London, Guildford, United Kingdom

Andras Strassz, MD^1*, Marc S. Raab, MD^2,3,4*, Robert Z. Orlowski, MD, PhD⁵, Michael Kulke, PhD^6*, Gudrun Schiedner, PhD^6* and Andreas Pahl, PhD⁷

¹Heidelberg Pharma AG, Ladenburg, Germany
²Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
³Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⁴Max-Eder-Group “Experimental Therapies for Hematologic Malignancies”, German Cancer Research Center, Heidelberg, Germany
⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁶Heidelberg Pharma GmbH, Ladenburg, Germany
⁷Heidelberg Pharma, Ladenburg, Germany

Francis K. Buadi, MB, CHB^1*, Martha Q. Lacy, MD¹, Gabriela Perez, MS^2*, Liang Phuong-Dung^3*, Ankit Kansagra, MD⁴, Thomas E. Witzig, MD⁵, Dania Kaehlyn Helgeson^6*, Karen Woolley^7*, Daniel Auclair⁸, Hearn Jay Cho, MD, PhD⁹ and Shaji K. Kumar, MD¹

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN
³Mayo Clinic, Rochester, MN
⁴Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Mayo Clinic, Rochester
⁷Multiple Myelom Research Foundation, Norwalk, CT
⁸Multiple Myeloma Research Foundation (MMRF), Norwalk, CT
⁹Multiple Myeloma Research Foundation, Norwalk, CT

James R. Berenson, MD¹, Noemi Silagan, MD^1*, Jennifer To, BS^2*, Tanya M. Spektor, PhD^1*, Daisy Martinez^1*, Armando J. Sanchez^1*, Eli Forouzan^1*, Regina Swift^3*, Benjamin Eades, PharmD^4*, Gary Schwartz, MD^5*, Shahrooz Eshaghian, MD⁶, Ralph V. Boccia, MD⁷, Honghao Hank Yang^8*, Stephen Lim, MD^9* and Robert Vescio, MD¹⁰

¹Oncotherapeutics, West Hollywood, CA
²Oncotherapeutics Inc., West Hollywood
³James R. Berenson, MD, Inc., West Hollywood, CA
⁴James Berenson MD, West Hollywood, CA
⁵James R. Berenson, MD, Inc, West Hollywood
⁶Compassionate Hematology & Oncology, Los Angeles, CA
⁷Center for Cancer and Blood Disorders, Bethesda, MD
⁸Global Oncology, Alhambra, CA
⁹Cedars-Sinai Medical Center, Los Angeles, CA
¹⁰Samuel Oschin Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Qiang Wang^1,2*, Zhijuan Lin, MD^3* and Qing Yi, MD, PhD¹

¹Center for Translational Research in Hematological Malignancies, Cancer Center, Houston Methodist Hospital, Houston, TX
²Center for Translational Research in Hematological Malignancies, Cancer Center, Research Institute of Houston Methodist Hospital, Houston, TX
³Houston Methodist Research Institute, Houston, TX

Noopur S. Raje, MD¹, David S. Siegel, MD², Sundar Jagannath, MD³, Sagar Lonial, MD⁴, Nikhil C. Munshi, MD⁵, Philippe Moreau, MD^6*, Hartmut Goldschmidt, MD⁷, Michele Cavo^8*, Anna Truppel-Hartmann, MD^9*, Everton Rowe, PhD^10*, Liping Huang, PhD^10*, Amit Agarwal, MD, PhD^10*, Julie Wang, PharmD, PhD^10*, Timothy B. Campbell, MD, PhD^10*, Jesus F. San-Miguel, MD, PhD¹¹ and Donna E. Reece, MD¹²

¹Massachusetts General Hospital, Boston, MA
²Hackensack University Medical Center, Hackensack, NJ
³Mount Sinai Hospital, New York, NY
⁴Emory School of Medicine, Atlanta, GA
⁵The LeBow Institute for Myeloma Therapeutic and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Centre Hospitalier Universitaire de Nantes, Nantes, France
⁷University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany
⁸Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁹bluebird bio, Cambridge, MA
¹⁰Bristol Myers Squibb, Princeton, NJ
¹¹Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Nararra, Spain
¹²Princess Margaret Cancer Centre, Toronto, ON, Canada

Evangelos Terpos, MD, PhD¹, Borhane Slama, MD^2*, Renato Zambello^3*, Sorina Nicoleta Badelita, MD^4*, Eirini Katodritou, MD^5*, Jo Caers, MD, PhD^6*, Thomas Kühr, MD^7*, Florence Suzan, MD^8*, Abeera Mohammad, MSc^9*, Sally Wetten, MSc^10* and Xavier Leleu, MD¹¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Service d'Hématologie, Centre Hospitalier d'Avignon, Avignon, France
³University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padova, Italy
⁴Institutul Clinic Fundeni, Bucharest, Romania
⁵Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁶Department of Hematology, CHU de Liège, Liege, Belgium
⁷Department of Internal Medicine IV, Academic Teaching Hospital Wels-Grieskirchen, Wels, Austria
⁸Amgen (Europe) GmbH, Rotkreuz, Switzerland
⁹Global Biostatistical Science, Amgen Ltd, Uxbridge, United Kingdom
¹⁰Centre for Observational Research, Amgen Ltd, Uxbridge, United Kingdom
¹¹Department of Oncology-Haematology and Cell Therapy, CHU Poitiers, INSERM, Inserm CIC 1402, Poitiers, France

Michael O'Dwyer, MD¹, Andrew Spencer, MBBS, FRACP, FRCPA, DM², Shaji K. Kumar, MD³, Rakesh Popat^4*, Philippe Moreau^5*, Monique Dail, PhD^6*, Muhammad Jalaluddin, PhD^7*, Xiaoqing Yang, PhD^7*, Xin Lu^7*, Zheng Zha^7*, Fengjiao Dunbar, PhD^7*, Deeksha Vishwamitra, PhD^7*, Christine Mantis, PhD^7*, Amal Melhem-Bertrandt, MD^7*, Jeremy A. Ross^7* and Simon J Harrison, MBBS MRCP (UK) PhD FRCPath (UK) FRACP⁸

¹National University of Ireland, Galway, Ireland
²School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Department of Hematology, University College London Hospitals, London, United Kingdom
⁵Department of Hematology, University Hospital, Nantes, France
⁶Genentech Inc., South San Francisco, CA
⁷AbbVie, Inc., North Chicago, IL
⁸Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

María-Victoria Mateos, MD, PhD¹, Albert Oriol^2*, Alessandra Larocca³, Joan Blade Creixenti⁴, Michele Cavo^5*, Paula Rodríguez-Otero, MD^6*, Xavier Leleu, MD⁷, Maxim Norkin, MD, PhD^8*, Omar Nadeem, MD^9*, John W. Hiemenz, MD^10*, Hani Hassoun, MD¹¹, Cyrille Touzeau^12,13,14*, Adrián Alegre Amor, MD, PhD^15*, Agne Paner, MD¹⁶, Christopher Maisel, MD¹⁷, Amitabha Mazumder, MD^18*, Anastasios Raptis, MD¹⁹, Noemí Puig, MD, PhD^1*, Johan Harmenberg, MD, PhD²⁰, Bengt Gustavsson, Dr Med Sci, MSc Pharm^20*, Marcus Thuresson, PhD^20* and Paul G. Richardson, MD⁹

¹Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
²Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
³Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy
⁴Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain
⁵Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁶Clínica Universidad de Navarra, Pamplona, Spain
⁷CHU de Poitiers, Poitiers, France
⁸Baptist MD Anderson Cancer Center, Jacksonville, FL
⁹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁰Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, FL
¹¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université d'Angers, Université de Nantes, Nantes, France
¹³Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France
¹⁴Service d'hématologie Clinique, Centre Hospitalier Universitaire, Place Alexis Ricordeau, Nantes, France
¹⁵Hospital Universitario La Princesa and Hospital Universitario Quironsalud, Madrid, Spain
¹⁶Rush University Medical Center, Chicago, IL
¹⁷Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX
¹⁸The Oncology Institute of Hope and Innovation, Glendale, CA
¹⁹Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
²⁰Oncopeptides AB, Stockholm, Sweden

Paula Rodriguez-Otero^1*, Mario Boccadoro², Roman Hajek, MD³, Tomoaki Fujisaki, MD^4*, Jae Hoon Lee, MD, PhD⁵, Joaquin Martinez-Lopez, MD^6*, Paulo Lucio, MD, PhD^7*, Zsolt Nagy, MD, PhD^8*, Ganna Usenko, MD^9*, Anna Marina Liberati, MD¹⁰, Mihaela Lazaroiu, MD¹¹, Dariusz Woszczyk, MD PhD^12*, Hiroyuki Takamatsu, MD, PhD¹³, Joanna Romejko-Jarosinska^14*, Stefan Tobias Knop^15*, Astrid Pavlovsky, MD^16*, Cecily Forsyth, FRACP, FRCPA, MBBS¹⁷, Takayuki Ishikawa, MD, PhD¹⁸, Katharine S. Gries, PhD, PharmD^19*, Huiling Pei, PhD^20*, Anupa Kudva, MD^21*, Jon Ukropec, PhD²², Susan Wroblewski, PhD^23*, Robin Carson, MD, BA²³ and Meletios A Dimopoulos²⁴

¹Clínica Universidad de Navarra, IDISNA, Navarra, Spain
²University of Torino, Turin, Italy
³University Hospital Ostrava, Faculty of Medicine and Faculty of Science, University of Ostrava, Ostrava, Czech Republic
⁴Matsuyama Red Cross Hospital, Matsuyama, Japan
⁵Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
⁶Hospital 12 de Octubre, H12O-CNIO, Haematological Malignancies Clinical Research Unit, Universidad Complutense, CIBERONC, Madrid, Spain
⁷Champalimaud Centre for the Unknown, Lisbon, Portugal
⁸Semmelweis Egyetem, Budapest, Hungary
⁹Head of City Hematology Center, City Clinical Hospital #4, Hematology Center, Dnepropetrovsk, Ukraine
¹⁰Azienda Ospedaliera "Santa Maria", Terni, Italy
¹¹Policlinica de Diagnostic Rapid, Brasov, Romania
¹²Hematology Department, University of Opole, Opole, Poland
¹³Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan
¹⁴Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
¹⁵Würzburg University Medical Center, Würzburg, Germany
¹⁶Fundaleu, Buenos Aires, Argentina
¹⁷Gosford Hospital, Gosford, NSW, Australia
¹⁸Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
¹⁹Janssen Global Services, LLC, Raritan, NJ
²⁰Janssen Research & Development, LLC, Titusville, NJ
²¹Janssen Research & Development, Raritan, NJ
²²Janssen Global Medical Affairs, Horsham, PA
²³Janssen Research & Development, LLC, Spring House, PA
²⁴National and Kapodistrian University of Athens, Athens, Greece

Roberto Mina, MD^*, Alessandra Larocca, Massimo Offidani, Vanessa Innao^*, Claudia Cellini^*, Monica Galli^*, Giusy Cetani^*, Mariella Grasso^*, Giovannino Ciccone^*, Andrea Capra^*, Sara Aquino^*, Claudia Priola^*, Gloria Margiotta Casaluci^*, Giovanni De Sabbata^*, Stelvio Ballanti^*, Michele Cavo^*, Mario Boccadoro and Sara Bringhen, MD

GIMEMA, European Myeloma Network, Italy

Yi Lin, MD, PhD¹, Thomas Martin III, MD², Adam D. Cohen, MD³, Andrzej Jakubowiak, MD, PhD⁴, Jagoda Jasielec, MD^4*, Saad Z. Usmani, MD, MBBS, MBA⁵, Deepu Madduri, MD^6*, Mounzer Agha, MD⁷, A. Keith Stewart, MBChB^8*, Indrajeet Singh, PhD^9*, Enrique Zudaire, PhD^9*, Tzu-Min Yeh^10*, Alicia J. Allred, PhD^9*, Yunsi Olyslager, MSc^11*, Arnob Banerjee, MD^9*, Jenna D. Goldberg, MD^10*, Jordan M. Schecter, MD¹⁰, Carolyn C. Jackson, MD, MPH^10*, William Deraedt, MSc^11*, Dong Geng, PhD^12*, Xiaoling Wu, PhD^12*, Marlene J. Carrasco, MD, PhD, MPH^12*, Muhammad Akram, MD^12*, Farah Hossain, PharmD^12*, Vickie Wang, PhD^12*, Jesus G. Berdeja, MD¹³ and Sundar Jagannath, MD^14*

¹Division of Hematology, Mayo Clinic, Rochester, MN
²University of California, San Francisco, San Francisco, CA
³Perelman Center, University of Pennsylvania, Philadelphia, PA
⁴University of Chicago, Chicago, IL
⁵Levine Cancer Institute, Charlotte, NC
⁶Mount Sinai Medical Center, New York, NY
⁷UPMC Hillman Cancer Center, Pittsburgh, PA
⁸UHN and the Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹Janssen R&D, Spring House, PA
¹⁰Janssen R&D, Raritan, NJ
¹¹Janssen R&D, Beerse, Belgium
¹²Legend Biotech USA Inc., Piscataway, NJ
¹³Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
¹⁴Department of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY

Marcelo Capra, MD, PhD¹, Thomas Martin III, MD², Philippe Moreau^3*, Ross Baker, MBBS, FRACP, FRCPA, BSc⁴, Ludek Pour, MD^5*, Chang-Ki Min, M.D, Ph.D.^6*, Xavier Leleu, MD⁷, Mohamad Mohty, MD, PhD⁸, Marta Reinoso Segura^9*, Mehmet Turgut, MD^10*, Richard Leblanc, MD, FRCPC¹¹, Marie-Laure Risse^12*, Laure Malinge^13*, Sandrine Schwab^13* and Meletios A Dimopoulos¹⁴

¹Departamento de Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil
²Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
³University of Nantes, Nantes, France
⁴Perth Blood Institute, Murdoch University, Perth, Australia
⁵University Hospital Brno, Brno, Czech Republic
⁶Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, Korea, Republic of (South)
⁷CHU and CIC Inserm 1402, Service D'Hématologie Et Thérapie Cellulaire, Poitiers Cedex, France
⁸Hôpital Saint-Antoine, Sorbonne University, INSERM UMRs 938, Paris, France
⁹Hospital Universitario Virgen del Rocio, Sevilla, Spain
¹⁰Ondokuz Mayis University Faculty of Medicine, Department of Hematology, Samsun, Turkey
¹¹Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
¹²Aixial (for Sanofi), Boulogne-Billancourt, France
¹³Sanofi R&D, Vitry/Alfortville, France
¹⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Larysa Sanchez, MD^1*, Dasha Cherepanov^2*, Dorothy Romanus, RPh, PhD^2*, Aditya Raju^3*, Marlo Blazer, PharmD^3*, Eileen Farrelly^3*, Dawn Marie Stull^2* and Sikander Ailawadhi, MD⁴

¹Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York
²Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
³Xcenda, LLC, Palm Harbor, FL
⁴Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL

Peter M. Voorhees^1*, Cesar Rodriguez, MD², Brandi Reeves, MD³, Nitya Nathwani, MD⁴, Luciano J. Costa, MD, PhD⁵, Yana Lutska, PharmD^6*, Padma Bobba^6*, Daniela Hoehn^6*, Huiling Pei, PhD^7*, Jon Ukropec, PhD⁸, Ming Qi, MD, PhD⁹, Thomas S. Lin, MD, PhD⁶ and Paul G. Richardson, MD¹⁰

¹Levine Cancer Institute, Atrium Health, Charlotte, NC
²Wake Forest University School of Medicine, Winston-Salem, NC
³University of North Carolina-Chapel Hill, Chapel Hill, NC
⁴Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, CA
⁵University of Alabama at Birmingham, Birmingham, AL
⁶Janssen Scientific Affairs, LLC, Horsham, PA
⁷Janssen Research & Development, LLC, Titusville, NJ
⁸Janssen Global Medical Affairs, Horsham, PA
⁹Janssen Research & Development, LLC, Spring House, PA
¹⁰Dana Farber Cancer Institute, Boston, MA

Lisa La¹, Sundar Jagannath, MD^1*, Sikander Ailawadhi, MD², Brian G.M. Durie, MD³, Cristina J. Gasparetto, MD^4*, James W. Hardin, PhD^5*, Hans C. Lee, MD⁶, Mohit Narang, MD^7*, James L. Omel, MD^8*, Robert M. Rifkin, MD⁹, Howard R. Terebelo, DO¹⁰, Kathleen Toomey, MD^11*, Lynne I. Wagner, PhD^12*, Mazaher Dhalla^13*, Liang Liu, MS^13*, Ling Yang, MS^13*, Prashant Joshi, MD^13* and Rafat Abonour, MD¹⁴

¹Mount Sinai Hospital, New York, NY
²Mayo Clinic, Jacksonville, FL
³Cedars-Sinai Medical Center, Los Angeles, CA
⁴Duke University Medical Center, Durham, NC
⁵University of South Carolina, Columbia, SC
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Maryland Oncology Hematology, US Oncology Research, Columbia, MD
⁸Myeloma Research Advocate/Advisor, Grand Island, NE
⁹Rocky Mountain Cancer Centers US Oncology Research, Denver, CO
¹⁰Providence Cancer Institute, Southfield, MI
¹¹Steeplechase Cancer Center, Somerville, NJ
¹²Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC
¹³Bristol-Myers Squibb Company, Princeton, NJ
¹⁴Indiana University, Indianapolis, IN

Maria Mateos, MD, PhD^1*, Sundar Jagannath, MD², Sosana Delimpasi, MD^3*, Maryana Simonova, MD^4*, Ivan Spicka, MD, PhD^5*, Ludek Pour, MD^6*, Irina Kryachok, MD^7*, Maria Gavriatopoulou^8*, Meletios A Dimopoulos⁹, Halyna Pylypenko, MD^10*, Holger W Auner, MD, PhD¹¹, Xavier Leleu, MD¹², Vadim A Doronin, MD^13*, Ganna Usenko, MD^14*, Reuben Benjamin, MD¹⁵, Tuphan Kanti Dolai, MBBS, MD, DNB, DM^16*, Dinesh Kumar Sinha, MD^17*, Christopher P. Venner, MD¹⁸, Mamta Garg, MD, FRCP, FRCPath^19*, Don A. Stevens, MD²⁰, Hang Quach, MD, FRACP, FRCPA, MBBS²¹, Philippe Moreau^22*, Moshe Y. Levy, MD²³, Ashraf Z. Badros, MD²⁴, Larry D. Anderson Jr., MD, PhD²⁵, Nizar Bahlis, MD²⁶, Thierry Facon, MD^27*, Michele Cavo^28*, Yi Chai^29*, Melina Arazy, MD^30*, Jatin Shah, MD²⁹, Sharon Shacham, PhD, MBA^29*, Michael G Kauffman, MD, PhD²⁹, Paul G. Richardson, MD³¹ and Sebastian Grosicki, MD, PhD³²

¹Hospital Clinico Universitario de Salamanca, Salamanca, Spain
²Department of Hematology and Medical Oncology, Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY
³Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁴Institute of Blood Pathology & Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, MA, Ukraine
⁵Charles University and General Hospital, Prague, Czech Republic
⁶University Hospital Brno, Brno, Czech Republic
⁷National Cancer Institute Ukraine, Kiev, Ukraine
⁸Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
¹⁰Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine
¹¹Imperial College Healthcare NHS Trust, London, United Kingdom
¹²Pôle Régional de Cancérologie, CHU de Poitiers, Poitiers, France
¹³Hematology Department, State Budget Healthcare Institution of Moscow, City Clinical Hospital #40 of Moscow Healthcare Department, Moscow, Russian Federation
¹⁴City Clinical Hospital No. 4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine
¹⁵Kings College Hospital NHS Foundation Trust, London, United Kingdom
¹⁶Haematology, NRS Medical College and Hospital, Kolkata, India
¹⁷Indira Gandhi Institute of Medical Sciences, Patna, India
¹⁸Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
¹⁹University Hospitals Leicester NHS Trust, Leicester, United Kingdom
²⁰Norton Cancer Institute - St Matthews Campus, Louisville, KY
²¹Melbourne Blood Specialist, East Melbourne, VIC, Australia
²²Department of Hematology, University Hospital of Nantes, Nantes, France
²³Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
²⁴University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²⁵Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX
²⁶University of Calgary, Calgary, AB, Canada
²⁷CHU Lille, Service des Maladies du Sang F-59000, Lille, France
²⁸Seragnoli Institute of Hematology, University of Bologna, Bologna, Italy
²⁹Karyopharm Therapeutics, Newton, MA
³⁰Karyopharm Therapeutics Inc., Newton, MA
³¹Dana-Farber Cancer Institute, Boston, MA
³²Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland

Eli Muchtar, MD^1*, Morie A Gertz, MD², Betsy Laplant, MS^3*, Francis K. Buadi, MB, CHB^1*, Nelson Leung, MD^1,2, Stephanie M. Peterson^4*, P. Leif Bergsagel, MD⁵, Amie Fonder, PA-C, MS^2*, Yi L. Hwa, NP², Miriam A. Hobbs, APRN, CNP, DNP^2*, Dania Kaehlyn Helgeson^6*, Alanna M. Vossen^2*, Wilson I Gonsalves, MD¹, Martha Q. Lacy, MD¹, Prashant Kapoor, MD¹, Mustaqeem A. Siddiqui, MD, MBA², Jeremy Larsen⁷, Rahma M Warsame, MD⁸, Suzanne R. Hayman, MD², Ronald S. Go, MD⁹, David Dingli, MD, PhD¹, Taxiarchis Kourelis, MD¹, Angela Dispenzieri, MD², S. Vincent Rajkumar, MD^10* and Shaji K. Kumar, MD¹

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN
⁴Department of Health Science Research, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic, Scottsdale, AZ
⁶Mayo Clinic, Rochester
⁷Mayo Clinic, Phoenix, AZ
⁸Mayo Clinic, Rochester, MN
⁹Mayo Clinic Rochester, Division of Hematology, Onalaska, WI
¹⁰Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Robert M. Rifkin, MD¹, Kevin Boyd, MB BS, BSc, MRCP, FRCPath, PhD^2*, Sebastian Grosicki, MD, PhD³, Kihyun Kim, MD, PhD⁴, Francesco Di Raimondo, MD⁵, Meletios A Dimopoulos⁶, Katja Weisel, MD^7*, Bertrand Arnulf, MD^8*, Roman Hajek, MD⁹, Vania T. M. Hungria, MD, PhD¹⁰, Andrew Spencer¹¹, Randy Davis, PhD^12*, Antonio Riccio, PhD, MBA^13*, Chanbin Kim^14*, Jodie Wilkes^15*, Ruth Rutledge^16*, Mala Talekar, MD^17*, Brandon E. Kremer, MD, PhD^17*, Ira Gupta, MD^17* and Maria-Victoria Mateos, MD, PhD¹⁸

¹Rocky Mountain Cancer Center, Denver, CO
²Royal Marsden Hospital, Sutton, United Kingdom
³School of Public Health, Medical University of Silesia, Katowice, Poland
⁴Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁵Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy
⁶Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
⁷University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
⁸Hematology/Oncology, Hôpital Saint-Louis, Paris, France
⁹Department of Hemato‐Oncology, University Hospital, Ostrava, Czech Republic
¹⁰São Germano Clinic, São Paulo, Brazil
¹¹Department of Clinical Haematology, Alfred Health-Monash University, Melbourne, Australia
¹²GlaxoSmithKline, Research Triangle Park, NC
¹³GlaxoSmithKline, Waltham, MA
¹⁴GlaxoSmithKline, Bethesda, MD
¹⁵GlaxoSmithKline, Stevenage, United Kingdom
¹⁶GlaxoSmithKline, Lansdale, MN
¹⁷GlaxoSmithKline, Philadelphia, PA
¹⁸Cancer Research Center-IBMCC (USAL-CSIC), University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

Laurie Eliason, MPH^1*, Julia Correll, MPH^2*, Mona Martin, MPA^2*, Anna Cardellino, MPH^3*, Joanna Opalinska, MD^3*, Trisha Piontek, BSN^4*, Boris Gorsh, PharmD^3*, Sandhya Sapra, PhD^3* and Rakesh Popat^5*

¹Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA
²Evidera, Seattle, WA
³GlaxoSmithKline, Upper Providence, PA
⁴GlaxoSmithKline, Philadelphia, PA
⁵University College London Hospitals, NHS Foundation Trust, London, United Kingdom